It would also be critical to elucidate whether DNMT3B plays similar roles in other cancers, especially other aggressive cancers characterized by activation of oncogenes (e.g., pancreatic cancer [90]), and whether PTS effects on DNMT3B binding and histone mark occupancy occur in different cancer types. This evidence concerns the gene DNMT3B and pancreatic neoplasm.